SCA
NVS icon

SAC Capital Advisors’s Novartis NVS Stock Holding History

SAC Capital Advisors’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-14,308
Closed -$1.09M – 702
2014
Q1 		$1.09M Buy
14,308
+4,789
+50% +$349K 0.01% 924
2013
Q4 		$686K Buy
9,519
+4,359
+84% +$303K ﹤0.01% 1045
2013
Q3 		$355K Buy
+5,160
New +$341K ﹤0.01% 1307

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BTS
BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
MAA
Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

SAC Capital Advisors's NVS Position: Q2 2014 in Review

SAC Capital Advisors sold out of Novartis (NVS) in Q2 2014, closing a stake of 14,308 shares — an estimated $1.09M sold.

SAC Capital Advisors first reported a position in NVS in Q3 2013 and held it in 3 quarters. The position peaked at $1.09M in Q1 2014. 847 funds tracked by Wall St. Rank hold NVS as of Q2 2014.

  • SAC Capital Advisors reported no remaining Novartis position as of Q2 2014 after selling out during the quarter.
  • SAC Capital Advisors sold 14,308 Novartis shares in Q2 2014, an estimated $1.09M.
  • SAC Capital Advisors first reported a position in Novartis in Q3 2013 and held it in 3 quarters.
  • SAC Capital Advisors's Novartis position peaked at $1.09M in Q1 2014.
  • 847 funds tracked by Wall St. Rank held Novartis as of Q2 2014.

Based on SAC Capital Advisors's 13F filing for Q2 2014.